Symposium 3

 

 

Day 1 : February 1, 2007 (Pre-symposium Workshop)

10.00 hrs
Spot Registration
10.30 hrs onwards Workshop
17.00 – 19.00 hrs Social Hours for all delegates
19.00 hrs Dinner
Day 2 : February 2, 2007
09.00 to 09.40 hrs
Inauguration ceremony
Session I
GLUCOSE METABOLISM AND ENERGY BALANCE

Chairpersons

  • Dr. S. D. Sheth, Consultant, ICMR
  • Dr. Richard DiMarchi, Indiana University
09.45 to 10.30 hrs

Keynote address (PL-1)

“An RNAi-based approach to understanding metabolic disease”

Dr. Michael Czech, Ph.D.
Professor, Department of Biochemistry and
Molecular Biology, and Director of the
Program in Molecular Medicine
University of Massachusetts, USA

10.30 to 11.00 hrs Tea break 
11.00 to 11.35 hrs

Invited Lecture
(IL-01)

"Glucose as a signal to control energy homeostasis"

Dr. Bernard Thorens
Professor of Physiology
Center for Integrative Genomics
University of Lausanne, Switzerland

11.35 to 12.10 hrs

Invited Lecture
(IL-02)

“Insulin and AMPK signalling in Skeletal Muscle: Validation of targets to prevent and treat Type 2 Diabetes Mellitus”

Dr. Juleen R. Zierath
Professor of Physiology
Department of Molecular Medicine and
Surgery
Karolinska Institute, Sweden

12.10 to 12.45 hrs

Invited Lecture
(IL-03)

“Forkhead transcription factors & Diabetes”

Dr. Markus Stoffel
Robert and Harriet Heilbrunn Professor,
Rockefeller University, USA

12.45 to 13.15 hrs

Invited Lecture
(IL-04)

“Cannabinoids and their regulation of metabolic syndrome”

Dr. Prasenjit Mitra
Group Leader
Zydus Research Centre

13.15 to 15.00 hrs   Lunch, Poster & Networking

Session II
ISLETS AND ENDOTHELIAL DYSFUNCTION

Chairpersons

  • Dr. Robert Henry, Professor of Medicine, University of California San Diego
15.00 to 15.35 hrs

Invited Lecture
(IL-05)

"Signal integration in the endocrine pancreas"

Dr. Per-Olof Berggren
Professor and Head, Experimental
Endocrinology at the Karolinksa Institute,
Stockholm, Sweden
Head of Cell Biology and Signal Tranduction
and the Mary Lou Held Visiting Scientist at
the Diabetes Research Institute, and Adjunct
Professor of Surgery at University of Miami,
USA

15.35 to 16.10 hrs

Invited Lecture
(IL-06)

 

"An Industry Perspective on New Therapeutic Approaches to Metabolic Disease"

Dr. David E. Moller, MD
Vice President, Endocrine and Cardiovascular
Research and Clinical
Investigation
Lilly Research Laboratories, USA

16.10 to 16.30 hrs   Tea break
16.30 to 17.05 hrs

Invited Lecture
(IL-07)

“AGPAT Isoforms and the Cellular Response to Fatty Acids”

Dr. Charles Burant, M.D., Ph.D.
Associate Professor
Metabolism, Endocrinology & Diabetes
University of Michigan, USA

17.05 to 17.35 hrs

Invited Lecture
(IL-08)

“Spatial and temporal regulation of insulin granule exocytosis”

Dr. Susumu Seino, M.D.
Professor
Division of Cellular & Molecular Medicine
Kobe University School of Medicine, Japan

17.35 to 18.30 hrs
Panel discussion

Chairperson
Dr. Richard DiMarchi, USA


Day 3 : February 3, 2007
Session III
HORMONES, NUCLEAR RECEPTORS AND METABOLISM
(ADIPOKINE, INCRETIN, INSULIN RESISTANCE, SIGNALING PATHWAYS, PPAR’s)

Chairpersons

  • Dr. C. M. Gupta, Director, CDRI, India
  • Dr. Per-Olof Berggren, Karolinska Institute, Sweden
09.15 to 10.00 hrs

Invited Lecture
(IL-09)

"Integrated Neurohormonal Therapy for Obesity"

Dr. Alain Baron
Senior Vice President, Research
Amylin

10.00 to 10.35 hrs
Invited Lecture
(IL-10)

“Cross-talk between nuclear receptors in metabolic
control and cardiovascular disease"

Dr. Bart Staels
INSERM
Institut Pasteur de Lille, France

10.35 to 11.00 hrs   Tea break 
11.00 to 11.35 hrs

Invited Lecture
(IL-11)

“Multifaceted role of PPAR gamma in the adipose tissue”

Dr. Walter Wahli
Director, Center for Integrative Genomics
Switzerland
11.35 to 12.10 hrs

Invited Lecture
(IL-12)

"Antiatherogenic properties of PPARgamma activators - novel effects beyond glucose control"

Dr. Nikolaus Marx
Professor
University of Ulm, Germany

12.10 to 12.45 hrs

Invited Lecture
(IL-13)

“Therapeutic mechanisms of PPAR gamma modulators”

Dr. Silvia Corvera
Professor
Program in Molecular Medicine
University of Massachusetts, USA

12.45 to 13.20 hrs

Invited Lecture
(IL-14)

"PPAR Based Therapy -How Do We Design Safer Compounds?"

Dr. Ashish Goel
Principal Scientist
NCE Discovery
Department of Cell Biology and Biochemistry
Zydus Research Centre

13.20 to 15.00 hrs   Lunch, Posters & Networking

Session IV ADVANCES IN TYPE 2 DIABETIC THERAPY

Chairpersons

  • Dr. P. Rama Rao, NIPER, India
  • Dr. Michael Czech, University of Massachusetts, USA
15.00 to 15.45 hrs

Keynote address (PL-4)

“Depot-Specific Regulation of Human Adipose Tissue Adiponectin Secretion”

Dr. Robert R. Henry, M.D., FRCP (C) (Ed)
Professor of Medicine
University of California San Diego
Chief, Section of Diabetes, Endocrinology &
Metabolism
Director, Center for Metabolic Research
VA San Diego Healthcare System, USA


15.45 to 16.20 hrs

Invited Lecture
(IL-15)

“New avenues in the Treatment of Type 2 Diabetes: Targeting insulin resistance beyond HbA1c - PPARs and non PPARs”

Dr. Elena Sebokova, Ph.D., D.Sc.
F. Hossmann La-Roche Ltd,
Disease Area Head Metabolic Disease,
Basel, Switzerland

16.20 to 16.35 hrs   Tea Break
16.35 to 17.10 hrs

Invited Lecture
(IL-16)

 

“Thiazolidinediones in Type 2 Diabetes: Indian Experience”

Dr. Anil Bhansali
Professor & Head, Endocrinology Postgraduate Institute of Medical Education & Reasearch, India

17.10 to 17.45 hrs
Invited Lecture
(IL-17)
Dr. Satinath Mukherjee
Associat Professor, Department of Endocrinology & Metabolism, Institute of Post Graduate Medical Education & Research, Kolkata, India
17.45 to 18.30 hrs
Panel discussion

Chairperson
Dr. Michael Czech, Ph.D., USA

18.30   Cultural Evening

Day 4 : February 4, 2007
Session V
DIABETES, DYSLIPIDEMIA AND RELATED COMPLICATIONS
(NEPHROPATHY, NEUROPATHY, AND RETINOPATHY)

Chairpersons

  • Dr. Shukan